JP2025506201A5 - - Google Patents
Info
- Publication number
- JP2025506201A5 JP2025506201A5 JP2024547842A JP2024547842A JP2025506201A5 JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5 JP 2024547842 A JP2024547842 A JP 2024547842A JP 2024547842 A JP2024547842 A JP 2024547842A JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- disease
- disability
- disorders
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310219P | 2022-02-15 | 2022-02-15 | |
| US63/310,219 | 2022-02-15 | ||
| PCT/US2023/012660 WO2023158584A1 (en) | 2022-02-15 | 2023-02-09 | New bicyclopentane derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506201A JP2025506201A (ja) | 2025-03-07 |
| JP2025506201A5 true JP2025506201A5 (enExample) | 2026-02-24 |
Family
ID=85781948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547842A Pending JP2025506201A (ja) | 2022-02-15 | 2023-02-09 | 新規なビシクロペンタン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250002452A1 (enExample) |
| EP (1) | EP4479377A1 (enExample) |
| JP (1) | JP2025506201A (enExample) |
| CN (1) | CN118829626A (enExample) |
| WO (1) | WO2023158584A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202400012724A1 (it) * | 2024-06-04 | 2025-12-04 | Angelini Pharma S P A | Composti attivatori dei canali potassio kv7.2/kv7.3 |
| IT202400012721A1 (it) * | 2024-06-04 | 2025-12-04 | Angelini Pharma S P A | Composti attivatori dei canali potassio kv7.2/kv7.3 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4200259A1 (de) | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
| JP7451543B2 (ja) | 2019-02-06 | 2024-03-18 | イーライ リリー アンド カンパニー | Ｋｃｎｑ増強剤としての１－（（２－（２，２，２－トリフルオロエトキシ）ピリジン－４－イル）メチル）尿素誘導体 |
| JP2023523402A (ja) * | 2020-04-29 | 2023-06-05 | イドーシア ファーマシューティカルズ リミテッド | スピロウレア誘導体 |
| JP2023531500A (ja) * | 2020-06-25 | 2023-07-24 | イドーシア ファーマシューティカルズ リミテッド | シクロブチル－ウレア誘導体 |
-
2023
- 2023-02-09 WO PCT/US2023/012660 patent/WO2023158584A1/en not_active Ceased
- 2023-02-09 EP EP23714122.1A patent/EP4479377A1/en active Pending
- 2023-02-09 CN CN202380020956.5A patent/CN118829626A/zh active Pending
- 2023-02-09 JP JP2024547842A patent/JP2025506201A/ja active Pending
-
2024
- 2024-08-14 US US18/804,965 patent/US20250002452A1/en active Pending